STUDIES OF CELL-MEDIATED-IMMUNITY TO HUMAN THYROID, RETROBULBAR AND LACRIMAL TISSUES, AND TO ANTI-THYROID DRUGS IN PATIENTS WITH GRAVES-DISEASE

被引：0
|
作者：
WALL, JR
FANG, SL
INGBAR, SH
BRAVERMAN, LE
机构：
[1] ST ELIZABETHS HOSP,BOSTON,MA
[2] TUFTS UNIV,SCH MED,BOSTON,MA 02111
来源：
NEW ZEALAND MEDICAL JOURNAL | 1976年 / 84卷 / 570期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [21] RESPONSE TO TRH, SERUM THYROID-HORMONE CONCENTRATION, AND SERUM MARKERS OF AUTO-IMMUNITY AFTER ANTI-THYROID THERAPY IN GRAVES-DISEASE
    LAMBERG, BA
    ARO, A
    SAARINEN, P
    TOTTERMAN, T
    MAKINEN, T
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1978, 1 (01) : 9 - 16
  • [22] RESPONSIVENESS TO THYROTROPIN RELEASING HORMONE AND THYROID SUPPRESSIBILITY IN GRAVES-DISEASE PATIENTS REMAINING IN REMISSION AFTER ANTI-THYROID DRUG-THERAPY
    RAJATANAVIN, R
    MAHATUMARAT, P
    POOCHANUGOOL, L
    KUMPOLPUNTH, S
    HIMATHONGKAM, T
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1981, 64 (01): : 11 - 18
  • [23] A PROSPECTIVE-STUDY OF THE RELATIONSHIP BETWEEN RELAPSE OF HYPERTHYROID GRAVES-DISEASE AFTER ANTI-THYROID DRUGS AND HLA HAPLOTYPE
    ALLANNIC, H
    FAUCHET, R
    LORCY, Y
    GUEGUEN, M
    LEGUERRIER, AM
    GENETET, B
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (04): : 719 - 722
  • [24] CELL-MEDIATED-IMMUNITY AND IMMUNE-COMPLEXES IN THYROID DISEASE
    CALDER, EA
    IRVINE, WJ
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1975, 4 (02): : 287 - 318
  • [25] LONG-TERM ANTI-THYROID DRUG-THERAPY FOR INTRACTABLE CASES OF GRAVES-DISEASE
    SHIZUME, K
    ENDOCRINOLOGIA JAPONICA, 1978, 25 (04): : 377 - 379
  • [26] THYROID ANTIGEN-INDUCED LEUKOCYTE PROCOAGULANT ACTIVITY - A NOVEL-APPROACH TO THE STUDY OF CELL-MEDIATED-IMMUNITY IN GRAVES-DISEASE AND HASHIMOTOS THYROIDITIS
    HOW, J
    THOMSON, AW
    MILTON, JI
    SCOTT, RM
    BEWSHER, PD
    HORNE, CHW
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1643 - 1643
  • [27] A murine model of Graves' disease applicable to analysis for new anti-thyroid drugs and their evaluation
    Fuse, T
    Kaneda, T
    Hakozaki, A
    Honda, A
    Tsuboi, K
    Yamamoto, U
    Mutou, A
    Yoshida, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 217P - 217P
  • [28] Use of anti-thyroid drugs in euthyroid pregnant women withi previous Graves' disease
    McNab, T
    Ginsberg, J
    CLINICAL AND INVESTIGATIVE MEDICINE, 2005, 28 (03): : 127 - 131
  • [29] Long-term outcomes of graves disease in children treated with anti-thyroid drugs
    Chiang, Ya-Ting
    Ting, Wei-Hsin
    Huang, Chi-Yu
    Huang, Shih-Kang
    Chan, Chon-In
    Cheng, Bi-Wen
    Lin, Chao-Hsu
    Wu, Yi-Lei
    Hung, Chen-Mei
    Li, Hsin-Jung
    Chan, Chia-Jung
    Lee, Yann-Jinn
    PEDIATRICS AND NEONATOLOGY, 2020, 61 (03): : 311 - 317
  • [30] CELL-MEDIATED-IMMUNITY IN GRAVES-DISEASE - EVALUATION BY COUNT OF ROSETTE-FORMING CELLS
    BIZZARRO, A
    CENNAMO, G
    BONAVOLONTA, G
    LEONARDI, E
    CASTELLO, G
    EXPERIMENTAL EYE RESEARCH, 1982, 35 (04) : 385 - 389
12345